Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Author/s
author: Julie Lang, Amy Jo Chien, Tufia C Haddad, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Judy Boughey, Claudine Isaacs, Debu Tripathy, Gregor Krings, Sarah L Blair, Gillian L Hirst, Scott Berry, Angela DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope Rugo, William Symmans, Laura J. van't Veer, Douglas Yee, Don Berry, Laura Esserman
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.